newsfilter
← Latest News
GlobeNewswire·

Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational Conference

HOUSTON, April 04, 2023 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for